Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 07, 2024

SELL
$185.0 - $326.08 $64.4 Million - $114 Million
-348,375 Reduced 77.32%
102,164 $20.3 Million
Q3 2023

Nov 13, 2023

SELL
$185.0 - $326.08 $64.4 Million - $114 Million
-348,375 Reduced 77.32%
102,164 $20.3 Million
Q2 2023

Oct 07, 2024

BUY
$226.52 - $324.64 $854,206 - $1.22 Million
3,771 Added 0.84%
450,539 $146 Million
Q2 2023

Aug 14, 2023

BUY
$226.52 - $324.64 $854,206 - $1.22 Million
3,771 Added 0.84%
450,539 $146 Million
Q1 2023

Oct 07, 2024

BUY
$229.06 - $278.01 $1.65 Million - $2 Million
7,196 Added 1.64%
446,768 $105 Million
Q1 2023

May 12, 2023

BUY
$229.06 - $278.01 $1.65 Million - $2 Million
7,196 Added 1.64%
446,768 $105 Million
Q4 2022

Oct 07, 2024

BUY
$164.02 - $259.76 $72.1 Million - $114 Million
439,572 New
439,572 $111 Million
Q4 2022

Feb 10, 2023

SELL
$164.02 - $259.76 $11.8 Million - $18.7 Million
-71,875 Reduced 14.05%
439,572 $111 Million
Q3 2022

Nov 14, 2022

BUY
$170.68 - $226.46 $27.7 Million - $36.7 Million
162,076 Added 46.39%
511,447 $90.7 Million
Q2 2022

Aug 12, 2022

SELL
$147.53 - $266.6 $10.8 Million - $19.5 Million
-72,970 Reduced 17.28%
349,371 $63.8 Million
Q1 2022

May 13, 2022

BUY
$193.94 - $261.91 $2.8 Million - $3.79 Million
14,452 Added 3.54%
422,341 $108 Million
Q4 2021

Feb 11, 2022

BUY
$207.57 - $280.17 $1.98 Million - $2.67 Million
9,518 Added 2.39%
407,889 $93.8 Million
Q3 2021

Nov 09, 2021

BUY
$170.0 - $258.58 $25.7 Million - $39 Million
150,886 Added 60.97%
398,371 $92.8 Million
Q2 2021

Aug 11, 2021

SELL
$164.93 - $242.23 $124 Million - $181 Million
-749,098 Reduced 75.17%
247,485 $47.8 Million
Q1 2021

May 11, 2021

BUY
$182.45 - $249.25 $71.7 Million - $98 Million
393,016 Added 65.12%
996,583 $206 Million
Q4 2020

Feb 09, 2021

SELL
$119.35 - $200.46 $7.95 Million - $13.4 Million
-66,612 Reduced 9.94%
603,567 $114 Million
Q3 2020

Nov 12, 2020

BUY
$87.5 - $130.91 $2.3 Million - $3.44 Million
26,303 Added 4.09%
670,179 $86.5 Million
Q2 2020

Aug 14, 2020

SELL
$49.5 - $97.93 $1.98 Million - $3.91 Million
-39,954 Reduced 5.84%
643,876 $56 Million
Q1 2020

May 14, 2020

SELL
$41.62 - $89.92 $12.4 Million - $26.9 Million
-298,638 Reduced 30.4%
683,830 $41.2 Million
Q4 2019

Feb 14, 2020

SELL
$52.12 - $75.0 $5.67 Million - $8.16 Million
-108,819 Reduced 9.97%
982,468 $72.9 Million
Q3 2019

Nov 14, 2019

BUY
$61.02 - $70.19 $5.87 Million - $6.75 Million
96,140 Added 9.66%
1,091,287 $66.6 Million
Q2 2019

Aug 14, 2019

BUY
$47.07 - $60.71 $2.17 Million - $2.8 Million
46,047 Added 4.85%
995,147 $60.4 Million
Q1 2019

May 15, 2019

BUY
$39.48 - $62.0 $6.66 Million - $10.5 Million
168,743 Added 21.62%
949,100 $53.9 Million
Q4 2018

Feb 14, 2019

BUY
$37.07 - $52.58 $20.1 Million - $28.5 Million
541,844 Added 227.18%
780,357 $33 Million
Q3 2018

Nov 14, 2018

BUY
$36.8 - $56.99 $8.78 Million - $13.6 Million
238,513 New
238,513 $10 Million

Others Institutions Holding INSP

About Inspire Medical Systems, Inc.


  • Ticker INSP
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 28,788,600
  • Market Cap $5.4B
  • Description
  • Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for m...
More about INSP
Track This Portfolio

Track Lord, Abbett & Co. LLC Portfolio

Follow Lord, Abbett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.